CGON
Price
$23.74
Change
-$0.39 (-1.62%)
Updated
May 9 closing price
Capitalization
1.81B
OLMA
Price
$4.60
Change
-$0.07 (-1.50%)
Updated
May 9 closing price
Capitalization
314.46M
3 days until earnings call
Ad is loading...

CGON vs OLMA

Header iconCGON vs OLMA Comparison
Open Charts CGON vs OLMABanner chart's image
CG Oncology
Price$23.74
Change-$0.39 (-1.62%)
Volume$1.94M
Capitalization1.81B
Olema Pharmaceuticals
Price$4.60
Change-$0.07 (-1.50%)
Volume$469.27K
Capitalization314.46M
CGON vs OLMA Comparison Chart
Loading...
CGON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OLMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CGON vs. OLMA commentary
May 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGON is a Hold and OLMA is a Hold.

Ad is loading...
COMPARISON
Comparison
May 11, 2025
Stock price -- (CGON: $23.74 vs. OLMA: $4.60)
Brand notoriety: CGON and OLMA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CGON: 101% vs. OLMA: 48%
Market capitalization -- CGON: $1.81B vs. OLMA: $314.46M
CGON [@Biotechnology] is valued at $1.81B. OLMA’s [@Biotechnology] market capitalization is $314.46M. The market cap for tickers in the [@Biotechnology] industry ranges from $296.96B to $0. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGON’s FA Score shows that 0 FA rating(s) are green whileOLMA’s FA Score has 1 green FA rating(s).

  • CGON’s FA Score: 0 green, 5 red.
  • OLMA’s FA Score: 1 green, 4 red.
According to our system of comparison, OLMA is a better buy in the long-term than CGON.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGON’s TA Score shows that 5 TA indicator(s) are bullish while OLMA’s TA Score has 5 bullish TA indicator(s).

  • CGON’s TA Score: 5 bullish, 5 bearish.
  • OLMA’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both CGON and OLMA are a good buy in the short-term.

Price Growth

CGON (@Biotechnology) experienced а -18.28% price change this week, while OLMA (@Biotechnology) price change was -18.15% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.24%. For the same industry, the average monthly price growth was +9.39%, and the average quarterly price growth was -13.47%.

Reported Earning Dates

CGON is expected to report earnings on May 08, 2025.

OLMA is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (-6.24% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CGON($1.81B) has a higher market cap than OLMA($314M). CGON YTD gains are higher at: -17.225 vs. OLMA (-21.098). CGON has higher annual earnings (EBITDA): -95.94M vs. OLMA (-135.54M). CGON has more cash in the bank: 541M vs. OLMA (215M). CGON has less debt than OLMA: CGON (296K) vs OLMA (1.7M). CGON has higher revenues than OLMA: CGON (684K) vs OLMA (0).
CGONOLMACGON / OLMA
Capitalization1.81B314M576%
EBITDA-95.94M-135.54M71%
Gain YTD-17.225-21.09882%
P/E RatioN/AN/A-
Revenue684K0-
Total Cash541M215M252%
Total Debt296K1.7M17%
TECHNICAL ANALYSIS
Technical Analysis
CGONOLMA
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
88%
Momentum
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 3 days ago
71%
Bullish Trend 3 days ago
84%
Declines
ODDS (%)
Bearish Trend 5 days ago
89%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
76%
View a ticker or compare two or three
Ad is loading...
CGON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OLMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BGPFX13.240.06
+0.48%
Baillie Gifford Developed EAFE All Cap 3
FCCVX33.56N/A
N/A
Fidelity Advisor Convertible Secs C
MFRHX55.16N/A
N/A
MFS Research R3
RSVIX13.99N/A
N/A
RBC Small Cap Value I
DCUSX13.05N/A
N/A
DWS CROCI US S

CGON and

Correlation & Price change

A.I.dvisor indicates that over the last year, CGON has been loosely correlated with ACLX. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if CGON jumps, then ACLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGON
1D Price
Change %
CGON100%
-1.62%
ACLX - CGON
57%
Loosely correlated
+2.29%
IDYA - CGON
55%
Loosely correlated
-4.18%
RCKT - CGON
54%
Loosely correlated
-0.71%
BHVN - CGON
53%
Loosely correlated
-0.05%
SYRE - CGON
53%
Loosely correlated
+9.64%
More

OLMA and

Correlation & Price change

A.I.dvisor indicates that over the last year, OLMA has been loosely correlated with RCKT. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if OLMA jumps, then RCKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OLMA
1D Price
Change %
OLMA100%
-1.50%
RCKT - OLMA
49%
Loosely correlated
-0.71%
IDYA - OLMA
47%
Loosely correlated
-4.18%
CRSP - OLMA
46%
Loosely correlated
-1.44%
CRNX - OLMA
46%
Loosely correlated
-6.18%
CGON - OLMA
45%
Loosely correlated
-1.62%
More